Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines

J Hematol Oncol. 2016 Oct 13;9(1):110. doi: 10.1186/s13045-016-0335-5.

Cornel Joseph Phillip^{1

2}, Shadia Zaman¹, Shujun Shentu¹, Kumudha Balakrishnan^{1

2}, Jiexin Zhang³, Veera Baladandayuthapani^{4

2}, Pietro Taverna⁵, Sanjeev Redkar⁵, Michael Wang⁶, Christine Marie Stellrecht^{1

2}, Varsha Gandhi^{7

8

9}

¹ Departments of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas, USA.
³ Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁴ Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Astex Pharmaceuticals, Inc., Dublin, California, USA.
⁶ Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁷ Departments of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [email protected].
⁸ Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [email protected].
⁹ Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas, USA. [email protected].

No abstract available

Publication types